Merck and Boltz Redefine AI Innovation in Protein Structure Prediction Through Global Hackathon In a landmark collaboration blending open science, artificial intelligence, and molecular biology, Merck, a leading science and technology company, joined forces with the Boltz team to host…
Merck Publishes Long-Term Phase 3 DeFi Trial Results Demonstrating Sustained Efficacy and Safety of OGSIVEO® (nirogacestat) for Desmoid Tumors in Journal of Clinical Oncology Merck, a leading science and technology company, announced the publication of long-term efficacy and safety findings…
Merck, a leading science and technology company, and Siemens, a global technology leader, have announced the signing of a new Memorandum of Understanding (MoU) that significantly extends their ongoing strategic partnership. The agreement is designed to accelerate digital transformation in…
Merck, a leading science and technology company, continues its organic growth. Despite ongoing geopolitical uncertainties, Group net sales in the second quarter of 2025 increased by 2.0% organically compared with the year-earlier quarter, while EBITDA pre rose by 4.6% organically.…
Merck Finalizes Sale of Surface Solutions Business to GNMI for €665 Million Merck, a global leader in science and technology, has officially concluded the sale of its Surface Solutions business to Global New Material International Holdings Ltd, a leading Chinese…
Merck KGaA, Darmstadt, Germany Finalizes $3.4 Billion Acquisition of SpringWorks Therapeutics Merck KGaA, Darmstadt, Germany, a global science and technology leader, has announced the completion of its acquisition of SpringWorks Therapeutics, Inc. for an enterprise value of $3.4 billion (approximately…
Neoclease Awarded Merck’s 2025 North American Advance Biotech Grant for Pioneering Gene-Editing Therapies Targeting Parkinson’s Disease Merck, a globally recognized leader in science and technology, has officially announced that Neoclease, an emerging biotech startup based in Boston, has been selected…
CDE Accepts Merck’s Pimicotinib NDA for TGCT Treatment Merck, a global leader in science and technology, has officially announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted its application for marketing…
Merck Unveils Comprehensive Oncology Advances at ASCO 2025, Targeting Advanced Cancers and Rare Tumors Merck, a global leader in science and technology innovation, today announced the presentation of a broad spectrum of new clinical data across more than a dozen…
Merck to Acquire SpringWorks Therapeutics to Strengthen its Healthcare Business and Drive Sustainable Growth Merck, a leading global science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company based in Stamford, Connecticut, today announced they have…
Merck Launches Global 2025 Curiosity Cube Tour, Inspiring the Next Generation of Scientists In an inspiring step toward making science education more inclusive and engaging, Merck, a prominent global leader in science and technology, officially launched its global 2025 Curiosity…
Merck and Zebra Technologies Partner for Safety and Traceability Solutions Merck, a leading science and technology company, has joined forces with Zebra Technologies Corporation, a global leader in digitizing and automating frontline workflows, to co-create innovative solutions that tackle pressing…